Mastellos, Dimitrios C.
Ricklin, Daniel http://orcid.org/0000-0001-6140-0233
Lambris, John D. http://orcid.org/0000-0002-9370-5776
Article History
Accepted: 13 June 2019
First Online: 19 July 2019
Competing interests
: J.D.L. is the founder of Amyndas Pharmaceuticals, which is developing complement inhibitors for therapeutic purposes. J.D.L. and D.R. are inventors of patents or patent applications that describe the use of complement inhibitors for therapeutic purposes, some of which are developed by Amyndas Pharmaceuticals. J.D.L. is also the inventor of the compstatin technology licensed to Apellis Pharmaceuticals (that is, 4(1MeW)7W/POT-4/APL-1 and PEGylated derivatives). D.C.M. declares no competing interests.